查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1840765

生物製藥輔料市場（按產品、供應商、配方類型和最終用戶分類）—2025-2032 年全球預測

Biopharmaceutical Excipients Market by Product, Source, Formulation Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年生物製藥輔料市場將成長至 77.2 億美元，複合年成長率為 9.94%。

主要市場統計數據
基準年2024年 36.1億美元
預計2025年 39.6億美元
預測年份：2032年 77.2億美元
複合年成長率（%） 9.94%

生物製藥輔料已遠遠超越了其在藥物製劑中作為惰性載體的傳統作用。如今，這些功能性成分被認為對藥物穩定性、生物有效性、可生產性和病患安全具有關鍵影響。隨著市場朝向複雜生技藥品、個人化療法和組合藥物方向發展，對輔料的需求呈指數級成長。決策者現在需要深入了解粘合劑、被覆劑、稀釋劑、崩壞、潤滑劑和其他類別的輔料在生產、儲存和運輸過程中如何與活性藥物成分相互作用。

本執行摘要概述了定義現代輔料市場的基本要素，為市場奠定了基礎。它提供了塑造行業發展的主要訊息，探討了影響全球供應供應商的監管和地緣政治趨勢，並根據產品、供應商、配方類型和最終用戶定義了關鍵細分市場。這個背景框架提供了對區域動態、競爭定位的洞察，並為尋求應對不確定性並利用新機會的行業領導者提供了切實可行的建議。

探索透過技術進步和監管創新塑造生物製藥輔料格局的快速變化

在製劑科學、數位技術和永續性要求的推動下，生物製藥輔料產業正在經歷轉型。在生技藥品和基因療法興起的推動下，製劑設計師正在引入新型聚合物粘合劑和標靶釋放被覆劑，以滿足敏感分子獨特的穩定性要求。同時，人工智慧和機器學習正在實現更具預測性的輔料篩檢，從而縮短開發時間並降低實驗失敗率。

此外，世界各地的監管機構正在加強輔料特性和安全方面的指導，鼓勵製造商採用更嚴格的「品質源於設計」原則。同時，該行業正在擁抱綠色化學，籌資策略專注於可再生、天然輔料和環保製造流程。因此，競爭格局正轉向那些能夠證明其可追溯性強、水分含量低且環境足跡較小的供應商，為創新和合規樹立了新的標竿。

2025年美國新關稅對生物製藥輔料供應鏈和成本結構影響的全面評估

美國2025年對各種進口輔料原料徵收關稅，為本已複雜的供應鏈帶來了新的複雜性。由於關稅影響關鍵的聚合物、多元醇和界面活性劑，製造商正努力應對不斷上漲的採購成本，而這些成本會波及配方預算和商業化計畫。這直接導致替代原料的搜尋速度顯著加快，人們對國內製造能力的興趣也重新燃起。

此外，關稅帶來的成本壓力凸顯了供應商關係敏捷性的重要性，迫使企業加強與受關稅影響較小的地區上游生產商的夥伴關係。同時，配方團隊正在重新審視輔料的規格，並尋找在不影響性能的情況下與低成本替代品進行對標的機會。總而言之，這些行動正在重塑輔料供應鏈管理流程，並要求整個價值鏈上的相關人員保持敏捷。

詳細分析產品來源配方和最終用戶細分，為生物製藥輔料市場策略提供可行的見解

對市場區隔的詳細研究可以揭示可為策略決策提供資訊的關鍵見解。按產品類型分類，市場包括粘合劑，例如纖維素衍生物、羥丙基甲基纖維素、聚維酮和改質澱粉；被覆劑，從控制釋放和腸溶包衣到薄膜和糖基；稀釋劑，例如磷酸鈣、乳糖和微晶纖維素；崩壞；潤滑劑；多元醇，例如甘露醇和山梨糖醇；防化劑和懸浮液以及懸浮液和表面活性劑；賦形劑來源可以是天然的，也可以是透過合成過程獲得的，每種工藝都有不同的純度水平、永續性概況和監管考慮。以劑型分類，市場包括注射劑（肌肉注射、靜脈注射和皮下注射）；口服劑型（膠囊、粉末和片劑）；以及外用劑型（乳膏、凝膠、軟膏和洗劑），每種劑型都需要特定的功能特性。最後，最終用戶的頻譜包括生物製藥和製藥製造商、合約開發和製造組織以及研究機構，這凸顯了相關人員必須應對的需求和籌資策略的多樣性。

美洲、歐洲、中東和非洲以及亞太地區生物製藥輔料市場的區域表現動態和成長軌跡

區域分析顯示，每個地區的成長動力因創新生態系統、法規環境和供應鏈能力而異。在美洲，對先進藥物輸送平台的強勁需求推動了對新型黏合劑和塗層技術的投資，而回流獎勵和關稅壓力（尤其是在美國）則推動了高純度輔料的國內生產。向東看，在嚴格的環境法規和促​​進跨境研發計劃的合作聯盟的推動下，歐洲、中東和非洲正在穩步吸收綠色和功能性輔料。同時，亞太地區仍然是產能擴張的溫床，中國、印度和東南亞的主要生產商利用成本競爭力和綜合供應鏈為區域和全球市場提供服務。各地區的一個一致主題是強調供應安全、可追溯性和監管完整性，因為製造商試圖減輕地緣政治風險並保持對關鍵原料的持續取得。

競爭情報揭示了主要產業參與者的策略性舉措以及推動生物製藥輔料產業成長的創新途徑

產業主要參與者正加緊努力，透過高性能輔料創新和策略夥伴關係來確保競爭優勢。一些領先的供應商已經建立了聚合物科學和奈米技術專業中心，從而能夠開發功能性包衣，以增強靶向釋放特性並提高患者依從性。同時，輔料製造商與學術研究機構之間的合作關係正在加速新型製劑平台的競爭前研究。

此外，企業正在利用數位平台提供整合生命週期管理服務，包括即時品質監控、生產線預測性維護以及與客戶進行材料資料的數位交換。鑑於近期關稅引發的供應鏈中斷，相關人員致力於確保原料的穩定供應，因此與特種化學品製造商和原料供應商的合作也不斷增加。這些策略舉措彰顯了該產業致力於透過技術、卓越服務和彈性籌資策略實現差異化的決心。

為產業領導者提供實際的策略建議，以加速創新、最佳化供應鏈並增強輔料開發的市場推廣

為了在這種動態環境中取得成功，產業領導者應採取多管齊下的策略。首先，整合地緣政治穩定的地區的二級供應商可以實現採購多元化，降低關稅風險並防止供應中斷。同時，投資模組化和靈活的製造能力，可以透過現有工廠和合約夥伴關係關係快速擴大和重新配置生產線。

此外，將研發預算轉向永續的輔料平台，使其在提供同等性能的同時減少生態足跡，既能滿足監管期望，又能滿足最終用戶的需求。與監管機構合作，為新型材料製定明確的品質標準，可以簡化核准流程。最後，利用數位工具進行預測分析和材料資訊學，可以提高配方成功率，縮短上市時間，並最終增強競爭優勢。

詳述數據收集三角測量和同行檢驗過程的穩健調查方法，支持對生物製藥輔料分析的洞察

本分析基於一套穩健的方法論，結合了全面的資料收集和專家檢驗。二次研究涵蓋了對監管指南、專利、白皮書和技術出版物的廣泛查閱，以了解關鍵輔料的功能屬性和合規性要求。隨後，我們也對領先生物製藥公司的配方科學家、採購負責人和監管專家進行了初步訪談，以獲得新興挑戰和最佳實踐的第一手見解。

為確保準確性和客觀性，資料點透過多個資訊來源進行三角測量，包括專有供應商資料庫和學術研究資料庫。定量輸入由材料性能測試報告支持，定性趨勢則透過迭代審查週期與行業專家進行交叉檢驗。這種結構化方法確保本文所呈現的調查結果能反映決策者可獲得的最新、最可靠且可操作的資訊。

綜合結論強調了生物製藥輔料產業的主要趨勢、挑戰和機遇，為決策提供參考

摘要：生物製藥輔料市場正處於科技創新、監管變革和地緣政治變化的十​​字路口。新一代粘合劑、被覆劑和輸送系統的變革潛力與應對新實施的關稅和供應鏈限制的緊迫性相得益彰。細分分析揭示了產品類型、供應商、配方類型和最終用戶的細微需求，而區域觀點則突顯了影響成長軌跡和投資重點的多樣化動態。

競爭格局正被那些在功能創新、永續實踐和供應鏈韌性方面表現卓越的企業重新定義。展望未來，那些擁抱多元化、數位化和協作監管的組織將更有能力抓住新的機會。最終，在這一領域的成功取決於將尖端科學與戰略遠見和敏捷營運相結合。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合數位雙胞胎技術實現預測性添加劑性能最佳化
  • 生物製藥製造中朝向永續和可生物分解的輔料邁進
  • 下一代生物製藥製造中擴大採用高純度、無動物性輔料
  • mRNA 疫苗開發對客製化輔料配方的需求不斷成長
  • 監管協調工作已使全球添加劑的認證標準標準化
  • 擴大輔料供應商與生技公司在新型輸送系統的合作
  • 擴大 cGMP 製造能力以滿足日益成長的生物添加劑需求
  • 供應鏈多角化策略，增強疫情後輔料採購的彈性

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：生物製藥輔料市場（按產品）

  • 黏合劑
    • 纖維素黏合劑
    • 羥丙基甲基纖維素（HPMC）
    • 聚維酮（聚乙烯吡咯烷酮或PVP）
    • 澱粉和改性澱粉
  • 塗層
    • 控釋包衣
    • 腸溶衣
    • 薄膜包衣
    • 密封塗層
    • 糖霜
  • 沖淡
    • 磷酸鈣
    • 乳糖
    • 微晶纖維素
  • 崩壞
  • 潤滑劑和助流劑
  • 多元醇
    • 甘露醇
    • 山梨糖醇
  • 防腐劑
  • 增溶劑和界面活性劑/乳化劑
    • 酯
    • 聚山梨醇酯
    • 三酸甘油酯
  • 懸浮劑和增稠劑

9. 生物製藥輔料市場（依來源）

  • 天然輔料
  • 合成輔料

第 10 章：生物製藥輔料市場（依配方類型）

  • 注射
    • 肌肉注射
    • 靜脈
    • 皮下
  • 口服製劑
    • 膠囊
    • 粉末
    • 藥片
  • 局部製劑
    • 奶油
    • 凝膠和軟膏
    • 洗劑

第 11 章：生物製藥輔料市場（以最終用戶分類）

  • 生物製藥和製藥公司
  • 契約製造
  • 研究機構

第 12 章：生物製藥輔料市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：生物製藥輔料市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章：各國生物製藥輔料市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • BASF SE
    • The Dow Chemical Company
    • ABITEC Corporation
    • Asahi Kasei Corporation
    • Actylis
    • Ashland Inc.
    • Avantor, Inc.
    • Clariant International Ltd.
    • Colorcon Ltd.
    • Croda International PLC
    • DFE Pharma GmbH & Co KG
    • Eastman Chemical Company
    • Evonik Industries AG
    • Fuji Chemical Industries Co., Ltd.
    • IMCD NV
    • Innophos Holdings, Inc.
    • International Flavors & Fragrances Inc.
    • JRS PHARMA GmbH+Co. KG
    • Kerry Group PLC
    • Meggle Group GmbH
    • Merck KGaA
    • Mitsubishi Chemical Group Corporation
    • NOF Corporation
    • Novo Nordisk A/S
    • Pfanstiehl, Inc.
    • Roquette Freres SA
    • Shin-Etsu Chemical Co., Ltd.
    • Sigachi Industries Limited
    • Spectrum Laboratory Products, Inc.
    • SPI Pharma, Inc. By Associated British Foods
    • The Archer-Daniels-Midland Company
    • The Lubrizol Corporation
    • Wacker Chemie AG
Product Code: MRR-A339DAEFAD78

The Biopharmaceutical Excipients Market is projected to grow by USD 7.72 billion at a CAGR of 9.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.61 billion
Estimated Year [2025] USD 3.96 billion
Forecast Year [2032] USD 7.72 billion
CAGR (%) 9.94%

Biopharmaceutical excipients have evolved far beyond their traditional role as inert carriers in drug formulation. Today, these functional ingredients are recognized for their critical influence on drug stability, bioavailability, manufacturability, and patient safety. As the landscape shifts toward complex biologics, personalized therapies, and combination products, the demands placed on excipients have grown exponentially. Decision makers now require a nuanced understanding of how binders, coatings, diluents, disintegrants, lubricants, and other categories interact with active pharmaceutical ingredients during production, storage, and delivery.

In this executive summary, we set the stage by outlining the foundational elements that define the modern excipients market. We introduce the primary drivers reshaping the industry, survey the regulatory and geopolitical currents that affect global supply chains, and delineate key segmentation dimensions by product, source, formulation type, and end user. With this contextual framework in place, we deliver insights into regional dynamics, competitive positioning, and actionable recommendations for industry leaders seeking to navigate uncertainty and capitalize on emerging prospects.

Exploring Rapid Transformations Reshaping the Biopharmaceutical Excipients Landscape Through Technological Advances and Regulatory Innovation

The biopharmaceutical excipients landscape is currently undergoing a wave of transformation fueled by advances in formulation science, digital technologies, and sustainability imperatives. Driven by the rise of biologics and gene therapies, formulators are increasingly incorporating novel polymeric binders and targeted release coatings to address the unique stability requirements of sensitive molecules. At the same time, artificial intelligence and machine learning are enabling more predictive excipient screening, accelerating development timelines and reducing experimental failure rates.

Furthermore, regulatory agencies around the world have tightened guidelines related to excipient characterization and safety, prompting manufacturers to adopt more rigorous quality by design principles. Concurrently, the industry is embracing green chemistry practices, with sourcing strategies focused on renewable natural excipients and ecofriendly manufacturing processes. As a result, the competitive environment is shifting toward suppliers that can demonstrate robust traceability, low aqueous content, and reduced environmental footprints, thereby creating a new benchmark for innovation and compliance.

Evaluating the Comprehensive Impact of Newly Implemented United States Tariffs in 2025 on Biopharmaceutical Excipients Supply Chain and Cost Structures

The implementation of United States tariffs in 2025 on a range of imported excipient raw materials has introduced fresh complexities into an already intricate supply chain. With levies impacting key polymers, polyols, and surfactants, manufacturers are grappling with higher procurement costs that ripple through formulation budgets and commercialization plans. As a direct consequence, there has been a marked acceleration in the search for alternative ingredient sources and a renewed interest in domestic production capabilities.

Moreover, the tariff-induced cost pressures have underscored the need for agility in supplier relationships, prompting companies to strengthen partnerships with upstream producers in regions less affected by these duties. In parallel, formulation teams are reexamining excipient specifications to identify opportunities for benchmarking lower-cost analogs without compromising performance. Collectively, these actions are reshaping the operational playbook for excipient supply chain management and demanding agile responses from stakeholders across the value chain.

In-Depth Analysis of Product Source Formulation and End User Segmentation Delivering Actionable Insights for Biopharmaceutical Excipients Market Strategy

A granular examination of market segmentation reveals pivotal insights that inform strategic decision making. When categorizing by product, the landscape spans binders such as cellulosic derivatives, hydroxypropyl methylcellulose, povidone, and modified starches; coatings ranging from controlled release and enteric to film and sugar-based variants; diluents including calcium phosphates, lactose, and microcrystalline cellulose; as well as disintegrants, lubricants, polyols like mannitol and sorbitol, preservatives, solubilizers and surfactants forming emulsifier systems, and suspending agents. Considering source, excipients derive from either natural origins or synthetic processes, each offering distinct purity, sustainability profiles, and regulatory considerations. In terms of formulation type, the market covers injectables with intramuscular, intravenous, and subcutaneous routes; oral delivery systems encompassing capsules, powders, and tablets; and topical forms such as creams, gels, ointments, and lotions, each demanding specific functional attributes. Finally, the end user spectrum, comprising biopharmaceutical and pharmaceutical manufacturers, contract development and manufacturing organizations, and research institutions, underscores the diversity of requirements and procurement strategies that stakeholders must navigate.

Regional Performance Dynamics and Growth Trajectories Across the Americas Europe Middle East Africa and Asia Pacific Biopharmaceutical Excipients Markets

Regional analysis underscores differentiated growth dynamics driven by local innovation ecosystems, regulatory environments, and supply chain capabilities. In the Americas, strong demand for advanced drug delivery platforms is catalyzing investment in novel binder and coating technologies, particularly in the United States where reshoring incentives and tariff pressures converge to support domestic manufacturing of high-purity excipients. Moving eastward, Europe, Middle East and Africa exhibit steady uptake of green and functional excipients, spurred by stringent environmental regulations and collaborative consortiums that foster cross-border R&D initiatives. Meanwhile, Asia-Pacific remains a hotbed of capacity expansion, with major producers in China, India, and Southeast Asia leveraging cost competitiveness and integrated supply chains to serve both regional and global markets. Consistent across all regions is an emphasis on supply security, traceability, and regulatory alignment, as manufacturers seek to mitigate geopolitical risks and maintain uninterrupted access to critical materials.

Competitive Intelligence Revealing Key Industry Players Strategic Initiatives and Innovation Pathways Driving Growth in Biopharmaceutical Excipients Sector

Key industry participants are intensifying efforts to secure competitive advantage through innovation in high-performance excipients and strategic partnerships. Several leading suppliers have established dedicated centers of excellence for polymer science and nanotechnology, enabling the development of functional coatings that enhance targeted release profiles and improve patient compliance. Simultaneously, collaborative alliances between excipient producers and academic research institutions are accelerating pre-competitive studies on novel formulation platforms.

In addition, companies are leveraging digital platforms to offer lifecycle management services that integrate real-time quality monitoring, predictive maintenance of production lines, and digital exchange of material data with customers. Partnerships with specialty chemical manufacturers and raw material providers are also on the rise, as stakeholders aim to ensure uninterrupted feedstock availability in light of recent tariff-driven supply chain disruptions. Taken together, these strategic initiatives underscore the industry's commitment to differentiation through technology, service excellence, and resilient sourcing strategies.

Actionable Strategic Recommendations Enabling Industry Leaders to Accelerate Innovation Optimize Supply Chains and Enhance Market Position in Excipients Development

To thrive in this dynamic environment, industry leaders should adopt a multi-pronged approach. First, diversifying sourcing by integrating second-tier suppliers from geopolitically stable regions can mitigate tariff risk and prevent disruptions. At the same time, investing in modular, flexible manufacturing capabilities-both in existing plants and through contract partnerships-will allow rapid scale-up or reconfiguration of production lines.

Furthermore, directing R&D budgets toward sustainable excipient platforms that deliver comparable performance with a reduced ecological footprint will address both regulatory expectations and end-user demand. Collaborative engagement with regulatory bodies to establish clear quality standards for novel materials can streamline approval timelines. Finally, harnessing digital tools for predictive analytics and material informatics will improve formulation success rates and accelerate time to market, ultimately enhancing competitiveness.

Robust Research Methodology Detailing Data Collection Triangulation and Expert Validation Processes Underpinning Insights in Biopharmaceutical Excipients Analysis

This analysis is built upon a robust methodology combining comprehensive data aggregation and expert validation. Initially, secondary research involved a thorough review of regulatory guidelines, patents, white papers, and technical publications to map the functional attributes and compliance requirements of key excipients. Following this, primary interviews were conducted with formulation scientists, procurement executives, and regulatory specialists from leading biopharmaceutical organizations to capture firsthand insights into emerging challenges and best practices.

To ensure accuracy and objectivity, data points were triangulated across multiple sources, including proprietary supplier databases and academic research repositories. Quantitative inputs were corroborated through material property testing reports, while qualitative trends were cross-verified with industry experts during iterative review cycles. This structured approach guarantees that the findings presented herein reflect the most current, reliable, and actionable intelligence available to decision makers.

Consolidated Conclusions Emphasizing Critical Trends Challenges and Opportunities to Inform Decision Making in the Biopharmaceutical Excipients Landscape

In summary, the biopharmaceutical excipients market stands at the intersection of scientific innovation, regulatory evolution, and geopolitical shifts. The transformative potential of next-generation binders, coatings, and delivery systems is now matched by the urgency to navigate newly imposed tariffs and supply chain constraints. Segmentation analysis reveals the nuanced requirements across product categories, sources, formulation types, and end users, while regional perspectives highlight the divergent dynamics that influence growth trajectories and investment priorities.

Competitive landscapes are being redefined by players that excel in functional innovation, sustainable practices, and supply chain resilience. Moving forward, organizations that embrace diversification, digitalization, and collaborative regulation will be best positioned to harness emerging opportunities. Ultimately, success in this sector will depend on the ability to integrate cutting-edge science with strategic foresight and operational agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of digital twin technologies for predictive excipient performance optimization
  • 5.2. Shift toward sustainable and biodegradable excipients in biopharmaceutical production
  • 5.3. Increasing adoption of high-purity, animal-free excipients for next-gen biologics manufacturing
  • 5.4. Rising demand for tailored excipient formulations in mRNA-based vaccine development
  • 5.5. Regulatory harmonization efforts driving standardized excipient qualification globally
  • 5.6. Growing collaborations between excipient suppliers and biotech firms for novel delivery systems
  • 5.7. Scaling up cGMP manufacturing capabilities to meet surging biologic excipient requirements
  • 5.8. Supply chain diversification strategies enhancing resilience in excipient sourcing post pandemic

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopharmaceutical Excipients Market, by Product

  • 8.1. Binders
    • 8.1.1. Cellulosic Binders
    • 8.1.2. Hydroxypropyl Methylcellulose (HPMC)
    • 8.1.3. Povidone (Polyvinylpyrrolidone or PVP)
    • 8.1.4. Starch & Modified Starches
  • 8.2. Coatings
    • 8.2.1. Controlled Release Coatings
    • 8.2.2. Enteric Coatings
    • 8.2.3. Film Coatings
    • 8.2.4. Seal Coatings
    • 8.2.5. Sugar Coatings
  • 8.3. Diluents
    • 8.3.1. Calcium Phosphates
    • 8.3.2. Lactose
    • 8.3.3. Microcrystalline Cellulose
  • 8.4. Disintegrants
  • 8.5. Lubricants & Glidants
  • 8.6. Polyols
    • 8.6.1. Mannitol
    • 8.6.2. Sorbitol
  • 8.7. Preservatives
  • 8.8. Solubilizers & Surfactants/Emulsifiers
    • 8.8.1. Esters
    • 8.8.2. Polysorbates
    • 8.8.3. Triglycerides
  • 8.9. Suspending & Viscosity Agents

9. Biopharmaceutical Excipients Market, by Source

  • 9.1. Natural Excipients
  • 9.2. Synthetic Excipients

10. Biopharmaceutical Excipients Market, by Formulation Type

  • 10.1. Injectable Formulations
    • 10.1.1. Intramuscular
    • 10.1.2. Intravenous
    • 10.1.3. Subcutaneous
  • 10.2. Oral Formulations
    • 10.2.1. Capsules
    • 10.2.2. Powders
    • 10.2.3. Tablets
  • 10.3. Topical Formulations
    • 10.3.1. Creams
    • 10.3.2. Gels & Ointments
    • 10.3.3. Lotions

11. Biopharmaceutical Excipients Market, by End User

  • 11.1. Biopharmaceutical & Pharmaceutical Companies
  • 11.2. Contract Manufacturers
  • 11.3. Research Institutes

12. Biopharmaceutical Excipients Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biopharmaceutical Excipients Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biopharmaceutical Excipients Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BASF SE
    • 15.3.2. The Dow Chemical Company
    • 15.3.3. ABITEC Corporation
    • 15.3.4. Asahi Kasei Corporation
    • 15.3.5. Actylis
    • 15.3.6. Ashland Inc.
    • 15.3.7. Avantor, Inc.
    • 15.3.8. Clariant International Ltd.
    • 15.3.9. Colorcon Ltd.
    • 15.3.10. Croda International PLC
    • 15.3.11. DFE Pharma GmbH & Co KG
    • 15.3.12. Eastman Chemical Company
    • 15.3.13. Evonik Industries AG
    • 15.3.14. Fuji Chemical Industries Co., Ltd.
    • 15.3.15. IMCD N.V.
    • 15.3.16. Innophos Holdings, Inc.
    • 15.3.17. International Flavors & Fragrances Inc.
    • 15.3.18. JRS PHARMA GmbH + Co. KG
    • 15.3.19. Kerry Group PLC
    • 15.3.20. Meggle Group GmbH
    • 15.3.21. Merck KGaA
    • 15.3.22. Mitsubishi Chemical Group Corporation
    • 15.3.23. NOF Corporation
    • 15.3.24. Novo Nordisk A/S
    • 15.3.25. Pfanstiehl, Inc.
    • 15.3.26. Roquette Freres S.A.
    • 15.3.27. Shin-Etsu Chemical Co., Ltd.
    • 15.3.28. Sigachi Industries Limited
    • 15.3.29. Spectrum Laboratory Products, Inc.
    • 15.3.30. SPI Pharma, Inc. By Associated British Foods
    • 15.3.31. The Archer-Daniels-Midland Company
    • 15.3.32. The Lubrizol Corporation
    • 15.3.33. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIOPHARMACEUTIC